Cachexia

Cancer-associated cachexia diagram

Cachexia

Cachexia is a complex metabolic syndrome characterized by significant weight loss, muscle wasting, fatigue, weakness, and loss of appetite. It is commonly associated with chronic illnesses such as cancer, chronic obstructive pulmonary disease (COPD), heart failure, and HIV/AIDS. The condition is often referred to as "wasting syndrome" due to the severe depletion of body mass and muscle tissue.

Symptoms

Individuals with cachexia may experience a range of symptoms, including unintentional weight loss, muscle atrophy, weakness, fatigue, anorexia, and decreased quality of life. The condition can significantly impact a person's ability to perform daily activities and may contribute to increased morbidity and mortality.

Causes

Cachexia is believed to result from a combination of factors, including systemic inflammation, metabolic abnormalities, and alterations in protein and energy metabolism. In chronic diseases, the body's response to inflammation can lead to the breakdown of muscle tissue and fat stores, contributing to the progressive wasting seen in cachexia.

Diagnosis

Diagnosing cachexia involves assessing a patient's weight loss, muscle mass, and functional status. Healthcare providers may use tools such as body mass index (BMI), bioelectrical impedance analysis, and blood tests to evaluate the extent of muscle wasting and nutritional deficiencies. It is essential to differentiate cachexia from other conditions that may cause weight loss, such as malnutrition or depression.

Treatment

The management of cachexia focuses on addressing the underlying disease, managing symptoms, and improving quality of life. Treatment strategies may include nutritional support, physical therapy, exercise programs, and medications to stimulate appetite and reduce inflammation. In some cases, interventions such as dietary supplements or appetite stimulants may be recommended to help maintain or restore body weight and muscle mass.

Prognosis

The prognosis for individuals with cachexia varies depending on the underlying cause and the effectiveness of treatment. In many cases, cachexia is a sign of advanced disease and may be associated with a poorer prognosis. Early recognition and intervention are crucial in improving outcomes and enhancing the quality of life for individuals affected by cachexia.

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian